Prostate Cancer Drug Improves COVID-19 Survival in Trial Prostate Cancer Drug Improves COVID-19 Survival in Trial
An experimental prostate cancer drug improved the survival of hospitalized COVID-19 patients in Brazil in a clinical trial, researchers reported on medRxiv ahead of peer review.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
More News: Brazil Health | Cancer | Cancer & Oncology | Clinical Trials | COVID-19 | Health | Infectious Diseases | Prostate Cancer